Mounjaro is a dual GIP and GLP-1 receptor agonist, although Wegovy functions solely over the GLP-one receptor. Mounjaro might have a more robust effect on entire body fat, but is not really completely authorised for fat reduction. Like Wegovy, Mounjaro is injected after each week.Considering that its European Union approval in January 2022 and subs